Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

HUGE
FSD Pharma Inc. Class B Subordinate Voting Shares
stock NASDAQ

Inactive
Aug 14, 2024
5.84USD-10.100%(-0.66)343,472
Pre-market
0.00USD-100.000%(-6.50)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Dec 2, 2021
08:06AM EST  FSD Pharma Unveils Videos Demonstrating Effects Of Lucid-MS In Treating Multiple Sclerosis In Pre-Clinical Models   Benzinga
Oct 19, 2021
08:45AM EDT  FSD Pharma Signs Agreement With Covar Pharmaceuticals To Support Development Of Lucid-PSYCH   Benzinga
Oct 18, 2021
08:36AM EDT  KCSA Psychedelics Virtual Investor Conference Presentations Available for   PR Newswire
Oct 13, 2021
08:01AM EDT  FSD Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on   PR Newswire
Aug 30, 2021
11:21AM EDT  Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold   Benzinga
Aug 25, 2021
05:10PM EDT  Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid Psycheceuticals   Benzinga
09:03AM EDT  FSD Pharma To Acquire Lucid Psycheceuticals; Transaction Will Involve Issuance Of ~4.5M Class B Share sOf FSD With Deemed Aggregate Purchase Price Of ~$9M   Benzinga
09:00AM EDT  FSD Pharma Announces Definitive Agreement to Acquire Lucid   GlobeNewswire Inc
07:30AM EDT  The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug   Benzinga
Aug 24, 2021
04:02PM EDT  FSD Pharma Inc. Announces Termination Of FSD-201 Phase 2 Clinical Trial   Benzinga
Jul 27, 2021
11:13AM EDT  FSD Pharma Inc. Announces Termination Of CEO Dr. Raza Bokhari For Cause   Benzinga
11:13AM EDT  FSD Pharma Says Reasons For Bokhari's Termination Include 'breaching court orders, the improper issuance of shares, and attempts to misappropriate Company funds in breach of his employment obligations'   Benzinga
May 5, 2021
08:37AM EDT  FSD Pharma Names Nathan Coyle Interim CFO   Benzinga
Apr 23, 2021
09:01AM EDT  FSD Pharma Files Proxy Materials, Sends Letter To Shareholders   Benzinga
Apr 5, 2021
07:30AM EDT  FSD Pharma Inc. Management Wasting Company Money by Seeking to Further Delay   PR Newswire
Mar 17, 2021
12:26PM EDT  Mid-Day Market Update: Dow Gains 100 Points; Rubius Therapeutics Shares Plummet   Benzinga
10:28AM EDT  FSD Pharma Inc. (HUGE) shares rising more than 18 percent on Wednesday morning trade as the company entered into license agreement to develop FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats.   RTTNews
05:33AM EDT  FSD Pharma Announced License Agreement to Develop FDA approved Veterinary Drugs for the Treatment of Gastro-Intestinal Diseases in Dogs and Cats   Benzinga
Mar 8, 2021
07:04AM EST  Court Orders FSD Pharma to Move Shareholder Meeting Date to May 14, 2021, Imposes Requirement of an Independent Meeting Chair and Prevents Dr. Raza Bokhari and Other Directors from Voting Recently Issued Shares   Benzinga
07:01AM EST  Imposes Requirement of an Independent Meeting Chair and Prevents Dr. Raza Bokhari and Other Directors from Voting Recently Issued Shares   PR Newswire
Feb 17, 2021
09:06AM EST  Enhancing Drug Delivery Systems With Lexaria's Technology   Benzinga
Feb 11, 2021
08:43AM EST  FSD Pharma Reports $20B At-The-Market Offering   Benzinga
08:40AM EST  FSD Pharma Announces US$20M At-The-Market Offering   Business Wire
Jan 26, 2021
07:30PM EST  FSD Provides Corporate Update   Business Wire
Jan 22, 2021
04:30PM EST  FSD Pharma Sets Date for Annual Meeting   Business Wire
Dec 16, 2020
03:26PM EST  Zacks Research Lowered Its Price Target On FSD Pharma From $11.70 To $9.20 Per Share   Benzinga
Dec 15, 2020
08:39AM EST  FSD Pharma Doses First Patient In Phase 2a Clinical Trial Of FSD201 For Treatment Of Hospitalized Patients With COVID-19   RTTNews
08:37AM EST  FSD Pharma Announces First Patient Randomized In Phase 2 Trial Of FSD201 For Treatment Of Hospitalized Patients With COVID-19   Benzinga
Nov 24, 2020
05:43AM EST  What's moving these stocks in the pre-market hours today?   RTTNews
Nov 12, 2020
05:00PM EST  FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update   Business Wire
Nov 5, 2020
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
Nov 3, 2020
07:38AM EST  The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 21, 2020
08:04AM EDT  The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings   Benzinga
Oct 16, 2020
07:30AM EDT  FSD Pharma Prices 3.45M Share Offering At $2.20/Share   Benzinga
Oct 5, 2020
07:31AM EDT  FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients   Benzinga
Aug 20, 2020
01:54PM EDT  FSD Pharma Shares Spike Higher; Hearing Brookline Capital Initiates Coverage With $11 Price Target   Benzinga
Jul 31, 2020
07:11PM EDT  The Week In Cannabis: Strong Earnings, Stocks In Green, Investments And Divestments   Benzinga
09:02AM EDT  FSD Pharma Prices ~2.76M Share Offering Of Shares, Warrants For ~1.38M Shares At $3.62/Share   Benzinga
01:00AM EDT  Canada-based FSD Pharma Inc. said it has informed Health Canada of its decision to forfeit the marijuana cultivation and sale licenses of its wholly-owned subsidiary, FV Pharma, Inc. and suspend all activities by FV Pharma within 30 days.   RTTNews
Jul 30, 2020
10:15AM EDT  Mid-Morning Market Update: Markets Open Lower; Procter & Gamble Tops Q4 Views   Benzinga
07:24AM EDT  FSD Pharma Says Working to Submit IND to FDA for the Use of FSD201 to Treat Hospitalized COVID-19 Patients   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC